Peapack Gladstone Financial Corp Buys 1,200 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Peapack Gladstone Financial Corp lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,718 shares of the healthcare conglomerate's stock after acquiring an additional 1,200 shares during the period. Peapack Gladstone Financial Corp's holdings in UnitedHealth Group were worth $41,348,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the third quarter valued at approximately $27,000. Macroview Investment Management LLC raised its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after buying an additional 47 shares during the period. Global Wealth Strategies & Associates raised its stake in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the period. Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares during the period. Finally, West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $4.72 during midday trading on Friday, hitting $520.48. The company's stock had a trading volume of 7,775,994 shares, compared to its average volume of 3,985,398. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average price is $583.29 and its 200-day moving average price is $559.30. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market capitalization of $478.99 billion, a PE ratio of 33.88, a price-to-earnings-growth ratio of 1.57 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $6.56 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.61%. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. HSBC lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, October 17th. Truist Financial reissued a "buy" rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $626.84.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.